Pharma Robots Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2032
The Pharma
Robots Market revenues were estimated at US$ 168.2 Mn in 2021 and is
anticipated to grow at a CAGR of 13.8% from 2022-2032, according to a recently
published Future Market Insights report. The market is expected to reach a
valuation of US$ 188.6 Mn in 2022 and US$ 683.4 Mn By the end of 2032.
Pharmaceutical Companies held the largest revenue share of
2/3rd in 2021 owing to the growing adoption by the manufacturing companies for
contamination control. Pharmaceutical companies are rapidly collaborating with
automation and robotics solution providers to incorporate these technologies
into operation including drug discovery, production, and anti-counterfeiting.
Personalized medicine is one area where robotics is projected to become more
prevalent in order to make it sustainable. Pharmaceutical companies have been
working with the providers of automation and robotics towards their integration
into processes including manufacturing, drug development, and
anti-counterfeiting.
For example, together Clemson University and Nephron
Pharmaceuticals Corporation have launched a benchtop robot capable of filling,
capping, and sealing sterile pre-filled syringes, saving money by averting drug
overfill and reducing adulteration. Without robots, filling syringes remains a
highly regulated process that must be carried out by specialized technicians in
ISO-certified clean rooms. The robot is intended to assist hospitals and
healthcare facilities in dealing with a scarcity of pre-filled syringes.
Key Takeaways from the Market Study
- Global
Pharma Robots Market is expected to reach a market size of US$ 188.6 Mn by
2022.
- The
Traditional Robots segment, is expected to account for the highest CAGR of
14.5% during the forecast period.
- United
States to remain the most dominant market with an absolute dollar growth
opportunity of US$ 153.4 Mn during 2022 – 2032.
- The
market in Japan is set to experience the highest CAGR of 16.1% during the
2022-2032 forecast period.
Competitive Landscape
The market is fiercely competitive, where key players are
increasingly focused to obtain a competitive advantage. The key companies in
the Pharma Robots Market are focused on R&D to produce innovative technological
solutions.
- In
December 2021, the Marchesini Group-Neri Division’s
BL-A309 was displayed at FCE Pharma, a flexible solution for
Print&Check and serialization processes that allow users to swiftly
install all of the major pharmaceutical traceability devices on the
market, from laser printers to ink-jet technologies.
- In
December 2021, Universal Robots launched a virtual pharma event,
where managers, experts, and other professionals in the pharmaceutical and
medical technology industries learned about the various possibilities that
robots provide. Universal Robots can be promising in the pharmaceutical industry
and are already generating a significant buzz in the market.
- In
May 2021, Fanuc augmented its SCARA robot line to provide more
reach and payload alternatives to companies that are looking to automate
assembly, packaging, pick-and-place, and inspection processes. New models
with payload capacities of 3, 6, and 20 kg are SR-3iA, SR-6iA, SR-12iA,
and SR-20iA. The reach of the models ranges from 400 to 1,000 mm.
Click For More Info: https://www.futuremarketinsights.com/reports/pharma-robots-market
Comments
Post a Comment